China Universal Asset Management Co., Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 72,943 shares of LXRX stock, worth $105,037. This represents 0.01% of its overall portfolio holdings.
Number of Shares
72,943
Previous 72,509
0.6%
Holding current value
$105,037
Previous $33,000
109.09%
% of portfolio
0.01%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LXRX
# of Institutions
130Shares Held
226MCall Options Held
431KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$196 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$56 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$14.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.85MShares$12.7 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$6.59 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $272M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...